Peak Bio

Palo Alto, United States

Peak Bio is a biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

$25.0M raised

Apr 2022

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Peak Bio raised?

Peak Bio has raised $25.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2022.

Who are Peak Bio's investors?

Peak Bio's investors include Palo Alto Investors, Hoyoung Huh.

Where is Peak Bio headquartered?

Peak Bio is headquartered in Palo Alto, United States.

What does Peak Bio do?

Peak Bio is a biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

What stage is Peak Bio at?

Peak Bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2022.

MLA

"Peak Bio — Funding & Investors." VCBacked, April 28, 2022, https://www.vcbacked.co/company/peak-bio. Accessed July 2, 2026.

APA

VCBacked. (2022). Peak Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/peak-bio

Wikipedia (cite web)

{{cite web |title=Peak Bio — Funding & Investors |url=https://www.vcbacked.co/company/peak-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2022.